33 completed, 14 terminated, 10 unknown, 6 active not recruiting. 76 Phase 2, 10 Phase 1, 9 Phase 3.
Follow Losartan: new trials by email Literature Review of Losartan trials Research Report on Losartan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer losartan, Paclitaxel - Platinum Resistant Ovarian Cancer | Phase 2 | Not yet recruiting | Massachusetts General Hospital | 27 | 2027-02-01 | 2026-09-22 |
| The GranStone Trial empagliflozin (Jardiance) 25 mg, Losartan 100 mg - Paraffinoma, Granuloma, Foreign-Body | Phase 2 / Phase 3 | Recruiting | Martin Blomberg Jensen | 100 | 2026-10-20 | 2026-11-10 |
| Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy BreakVax, Ipilimumab 2.5 mg, Pembrolizumab - Glioblastoma (GBM) | Phase 1 / Phase 2 | Not yet recruiting | BreakBio Corp | 10 | 2026-09-01 | 2026-08-19 |
| Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy BreakVax, Ipilimumab 2.5 mg, Pembrolizumab - Triple-Negative Breast Cancer (TNBC) | Phase 1 / Phase 2 | Not yet recruiting | BreakBio Corp | 10 | 2026-09-01 | 2026-08-19 |
| Losartan to Improve Outcomes After Multi-ligament Knee Injury losartan 25 mg, Placebo capsule - Multi-ligament Knee Injury | Phase 2 | Recruiting | Brigham and Women's Hospital | 90 | 2025-10-01 | 2026-01-20 |
| Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis. Losartan, Placebo - Cystic Fibrosis | Phase 2 | Recruiting | University of Kansas Medical Center | 42 | 2024-06-03 | 2025-05-02 |
| Polypill for Prevention of Cardiomyopathy Polypill, Combined prescription of the individual medications - Type 2 Diabetes, High Blood Pressure | Phase 1 / Phase 2 | Recruiting | University of Texas Southwestern Medical Center | 200 | 2024-03-11 | 2026-08-04 |
| Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan Losartan, Placebo - Losartan - Knee Arthroplasty, Total | Phase 1 / Phase 2 | Recruiting | Steadman Philippon Research Institute | 120 | 2024-03-06 | 2024-03-12 |
| Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients Losartan - Peripheral Neuropathy Due to Chemotherapy | Phase 2 | Completed | Future University in Egypt | 84 | 2023-12-12 | 2025-04-24 |
| Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients Losartan 25 milligram capsule, Placebo - Radiation Induced Fibrosis | Phase 2 | Active not recruiting | Shaw Cancer Center | 43 | 2023-08-17 | 2026-06-18 |
| Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients Losartan 50mg Tab - Chemotherapy, Colorectal Cancer | Phase 2 | Unknown | Ain Shams University | 80 | 2023-07-17 | 2023-07-19 |
| GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer Losartan, Gemcitabine, Nab paclitaxel - Pancreatic Cancer | Phase 2 | Withdrawn | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2023-06-14 | 2024-12-27 | |
| Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study) Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine), PCP - Cognitively Normal Older Adults, Hypertension | Phase 2 | Active not recruiting | Rong Zhang | 180 | 2022-10-25 | 2026-07-21 |
| FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer FOLFIRNINOX, Losartan, 9-ING-41 - Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic | Phase 2 | Active not recruiting | Colin D. Weekes, M.D., PhD | 70 | 2022-03-21 | 2026-09-11 |
| The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blockers - Oxidative Stress | Phase 2 | Completed | Unidad de Investigacion Medica en Enfermedades Renales | 39 | 2022-01-01 | 2022-02-09 |
| Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy Camrelizumab, Liposomal Doxorubicin, Losartan - Breast Cancer | Phase 2 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 52 | 2021-10-01 | 2021-10-28 |
| Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease Losartan - Sickle Cell Disease, Diffuse Myocardial Fibrosis | Phase 2 | Completed | Children's Hospital Medical Center, Cincinnati | 14 | 2021-09-01 | 2026-06-12 |
| NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer Capecitabine, Fluorouracil, Irinotecan Hydrochloride - Pancreatic Adenocarcinoma, Stage 0 Pancreatic Cancer American Joint Committee on Cancer v8 | Phase 2 | Active not recruiting | OHSU Knight Cancer Institute | 42 | 2021-05-27 | 2026-01-14 |
| Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis Fisetin, Losartan, Placebo - Losartan - Osteoarthritis, Knee | Phase 1 / Phase 2 | Unknown | Steadman Philippon Research Institute | 100 | 2021-05-18 | 2024-04-16 |
| Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS Losartan 50 mg and Spironolactone 25 mg pillules oral use - COVID-19, ARDS | Phase 2 | Terminated | Assistance Publique Hopitaux De Marseille | 78 | 2020-09-11 | 2024-06-24 |
Showing 20 of 76. Sign in to see all of them.
Hypertension (17) · COVID-19 (6) · Coronavirus Infections (4) · Fibrosis (4) · Kidney Diseases (4) · Anemia, Sickle Cell (3) · Breast Neoplasms (3) · Inflammation (3) · Non-alcoholic Fatty Liver Disease (3) · Pancreatic Neoplasms (3) · Alzheimer Disease (2) · Camurati-Engelmann Syndrome (2) · Cardiomyopathy, Hypertrophic (2) · Cystic Fibrosis (2) · Dementia (2)
Massachusetts General Hospital (5) · Children's Hospital Medical Center, Cincinnati (4) · Steadman Philippon Research Institute (3) · University of Minnesota (3) · BreakBio Corp (2) · Hanmi Pharmaceutical Company Limited (2) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · University of Alabama at Birmingham (2) · University of Texas Southwestern Medical Center (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Ain Shams University (1) · Alicia Gerke (1) · Assistance Publique Hopitaux De Marseille (1) · Bassett Healthcare (1) · Brigham and Women's Hospital (1)
United States (48) · Canada (6) · Italy (4) · Taiwan (4) · Brazil (3) · Mexico (3) · South Korea (3) · Denmark (2) · Egypt (2) · Germany (2) · Netherlands (2) · Poland (2) · Argentina (1) · Chile (1) · China (1)
Christopher Tignanelli, MD (2) · Johnny Huard, PhD (2) · Michael Puskarich, MD, MS (2) · Rong Zhang, PhD (2) · Adrian Camacho Ortiz, MD (1) · Alicia K Gerke, MD (1) · Ambarish Pandey, MD, MSCS (1) · Antonino Romeo, MD (1) · Astrid M Horstman, PhD (1) · Barbara J Morgan, PhD, PT (1) · Bianchi Giuseppe, MD (1) · Bret Goodpaster, PhD (1) · Cale Jacobs, PhD (1) · Charles Bengtson, MD, MSc (1)
PMID 32658300, PMID 41486497, PMID 19073787, PMID 19571282, PMID 19932542, PMID 20142543, PMID 21310077, PMID 21715517, PMID 22217192, PMID 23321647, PMID 24050942, PMID 24408116, PMID 24621999, PMID 25465809, PMID 25533774, PMID 26198842, PMID 26661322, PMID 27388615, PMID 28589652, PMID 29222139, PMID 29750475, PMID 29767459, PMID 29992039, PMID 30541065, PMID 30826452, PMID 31145418, PMID 31532959, PMID 31710528, PMID 32039215, PMID 32588430, PMID 32716358, PMID 33107592, PMID 33252490, PMID 33408462, PMID 33649520, PMID 34136782, PMID 34195577, PMID 34473343, PMID 35224732, PMID 35229827, PMID 35294537, PMID 35511890, PMID 35636733, PMID 36749631, PMID 37861929, PMID 37871959, PMID 38682786, PMID 39082471, PMID 40337980, PMID 40434633
1UG3AR077748-01 (1), 2008 (1), 2018 (1), K23HL127100 (1), P30AG021334 (1), R01AG076660 (1), R03DK096157 (1), R33DK070341 (1), U01AG050499 (1), U01AI105872 (1), U01DK061730 (1), U01HL105365 (1), U54AI117804 (1)